ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,561Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 113

$843K Total Retail Price of All Prescriptions

Rank: 1 out of 113

754 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 754 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 754 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 14,817 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 902 824 1 1
SIMVASTATIN 704 665 2 2
LISINOPRIL 591 555 3 3
WARFARIN SODIUM 527 494 4 8
AMLODIPINE BESYLATE 408 383 5 4
METOPROLOL SUCCINATE 403 381 6 10
FUROSEMIDE 376 367 7 6
HYDROCHLOROTHIAZIDE 368 353 8 9
HYDROCODONE-ACETAMINOPHEN 309 293 S3 9 7
OMEPRAZOLE 309 252 9 5
ATORVASTATIN CALCIUM 297 260 11 15
LOSARTAN POTASSIUM 297 259 11 13
GABAPENTIN 291 238 13 18
METOPROLOL TARTRATE 279 263 14 14
POTASSIUM CHLORIDE 256 245 15 12
METFORMIN HCL 255 207 16 11
ATENOLOL 230 214 17 16
ALENDRONATE SODIUM 228 210 18 22
FLUOXETINE HCL 199 168 19 31
SERTRALINE HCL 195 179 20 21
DIGOXIN 188 183 21 27
CRESTOR 176 176 22 30
CITALOPRAM HBR 174 170 23 17
ALLOPURINOL 169 141 24 20
TORSEMIDE 161 143 25 102
PREDNISONE 158 152 26 28
CARVEDILOL 141 138 27 25
DONEPEZIL HCL 136 136 28 33
DIOVAN 132 129 29 42
TAMSULOSIN HCL 129 129 30 24
AZITHROMYCIN 114 97 31 65
TRAMADOL HCL 110 108 32 29
TRIAMTERENE-HCTZ 108 105 33 26
ZOLPIDEM TARTRATE 107 101 34 19
SYNTHROID 105 105 35 57
CLOPIDOGREL 99 84 36 56
CYMBALTA 98 67 37 37
SPIRONOLACTONE 98 83 37 32
DILTIAZEM ER 97 97 39 92
CIPROFLOXACIN HCL 97 76 39 63
GLYBURIDE 94 76 R 41 66
FINASTERIDE 93 93 42 87
PLAVIX 92 88 43 81
FLUTICASONE PROPIONATE 88 84 44 39
PREMARIN 88 88 R 44 69
DOXAZOSIN MESYLATE 86 78 46 49
SULFAMETHOXAZOLE-TRIMETHOPRIM 86 70 46 140
NEXIUM 84 52 48 47
TRIAMTERENE-HYDROCHLOROTHIAZID 84 65 48 91
VERAPAMIL ER 83 77 50 123
VENLAFAXINE HCL ER 80 79 51 55
KLOR-CON M20 77 73 52 60
LOSARTAN-HYDROCHLOROTHIAZIDE 75 75 53 40
ZETIA 74 74 54 80
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 56 55 34
OLANZAPINE 72 67 56 88
JANUVIA 71 61 57 85
VENTOLIN HFA 71 62 57 110
BUPROPION XL 70 47 59 101
LOVASTATIN 70 66 59 53
ENALAPRIL MALEATE 70 70 59 50
PROAIR HFA 69 49 62 64
DOXYCYCLINE HYCLATE 67 51 63 176
LEVETIRACETAM 66 55 64 117
QUETIAPINE FUMARATE 61 55 65 83
OXYBUTYNIN CHLORIDE ER 60 38 66 112
POLYETHYLENE GLYCOL 3350 59 48 67 77
MELOXICAM 58 54 68 44
METHYLPREDNISOLONE 58 55 68 147
PRAVASTATIN SODIUM 58 53 68 23
TRAZODONE HCL 58 51 68 41
PAROXETINE HCL 56 44 72 45
LANTUS SOLOSTAR 56 36 72 59
KLOR-CON 10 56 56 72 68
FLOVENT HFA 55 52 75 192
CYCLOBENZAPRINE HCL 55 28 R 75 76
FELODIPINE ER 54 54 77 95
BACLOFEN 54 42 77 137
ADVAIR DISKUS 53 51 79 35
LIPITOR 52 46 80 159
CARBIDOPA-LEVODOPA 52 52 80 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.